Finch Therapeutics Group, Inc. Quarterly Return On Equity in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Finch Therapeutics Group, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2024.
  • Finch Therapeutics Group, Inc. Return On Equity for the quarter ending June 30, 2024 was -69.1 %, a 64.7% increase year-over-year.
  • Finch Therapeutics Group, Inc. annual Return On Equity for 2023 was -269 %, a 226% decline from 2022.
  • Finch Therapeutics Group, Inc. annual Return On Equity for 2022 was -82.6 %, a 216% decline from 2021.
  • Finch Therapeutics Group, Inc. annual Return On Equity for 2021 was -26.2 %, a 154% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -69.1 +127 +64.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -68.1 +80.5 +54.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -269 -186 -226% Oct 1, 2023 Dec 31, 2023
Q3 2023 -215 -150 -233% Jul 1, 2023 Sep 30, 2023
Q2 2023 -196 -156 -389% Apr 1, 2023 Jun 30, 2023
Q1 2023 -149 -116 -349% Jan 1, 2023 Mar 31, 2023
Q4 2022 -82.6 -56.4 -216% Oct 1, 2022 Dec 31, 2022
Q3 2022 -64.5 -29.2 -82.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -40.1 +33 +45.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -33.1 -1.08K -103% Jan 1, 2022 Mar 31, 2022
Q4 2021 -26.2 -74.7 -154% Oct 1, 2021 Dec 31, 2021
Q3 2021 -35.3 Jul 1, 2021 Sep 30, 2021
Q2 2021 -73.1 Apr 1, 2021 Jun 30, 2021
Q1 2021 1.05K Jan 1, 2021 Mar 31, 2021
Q4 2020 48.6 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.